Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for SeaStar Medical Holding (ICUCW) over the last 3 years, with Q2 2025 value amounting to -$16000.0.

  • SeaStar Medical Holding's Gains from Investment Securities rose 9914.89% to -$16000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$108000.0, marking a year-over-year decrease of 10536.51%. This contributed to the annual value of $697000.0 for FY2024, which is 22788.99% up from last year.
  • Per SeaStar Medical Holding's latest filing, its Gains from Investment Securities stood at -$16000.0 for Q2 2025, which was up 9914.89% from -$16000.0 recorded in Q1 2025.
  • In the past 5 years, SeaStar Medical Holding's Gains from Investment Securities ranged from a high of $2.8 million in Q1 2024 and a low of -$1.9 million during Q2 2024
  • In the last 3 years, SeaStar Medical Holding's Gains from Investment Securities had a median value of -$56000.0 in 2023 and averaged $12100.0.
  • The largest annual percentage gain for SeaStar Medical Holding's Gains from Investment Securities in the last 5 years was 800555.56% (2024), contrasted with its biggest fall of 16002.77% (2024).
  • Quarter analysis of 3 years shows SeaStar Medical Holding's Gains from Investment Securities stood at $1.2 million in 2023, then tumbled by 106.13% to -$76000.0 in 2024, then surged by 78.95% to -$16000.0 in 2025.
  • Its last three reported values are -$16000.0 in Q2 2025, -$16000.0 for Q1 2025, and -$76000.0 during Q4 2024.